This federal contract award, identified as SPE2D021D0008|SPE2D324F185K, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, American Regent Inc. The contract is for the delivery of atropine sulfate injection, a critical care medication used in emergency situations. The award is a firm-fixed-price delivery order with a ceiling value of $1,852.50 and an ultimate completion date of August 13, 2024.
American Regent Inc. is a pharmaceutical manufacturer and distributor that specializes in injectable drugs and other sterile pharmaceutical preparations. The company primarily provides these products to the U.S. federal government, with a focus on supporting military healthcare programs and maintaining medical readiness for the armed forces. This contract award is not associated with any set-aside designation, indicating American Regent's capacity to compete in full and open competition.
In addition to this specific delivery order, American Regent Inc. holds two significant federal contract indefinite delivery vehicles (IDVs). The first is a $131.4 million multiple award Federal Supply Schedule (FSS) contract with the U.S. Department of Veterans Affairs (VA), allowing the company to supply hematology-related pharmaceutical products to VA health centers. The second is a $13.8 million single award indefinite delivery/indefinite quantity (IDIQ) contract with the DLA Troop Support Medical, under which American Regent provides various pharmaceuticals, including atropine, glycopyrrolate, and hydroxyzine, to support military medical treatment facilities worldwide.
Generated 11/7/24, 9:11 AM